CEFTAZIDIME QILU 1 g, powder for solution for injection/for infusion (IM, IV) bottle, 15 ml
Active ingredients: Anhydrous ceftazidime, CEFTAZIDIME PENTAHYDRATÉE AVEC DU CARBONATE DE SODIUM POUR PRÉPARATIONS INJECTABLES
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection or infusionbottle, 15 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFTAZIDIME QILU 1 g, poudre pour solution injectable/pour perfusion (IM, IV)
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 15 ml
- Marketing authorisation holder
- QILU PHARMA SPAIN (ESPAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66788028CIP73014673CIP133400930146736Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFTAZIDIME PENTAHYDRATÉE AVEC DU CARBONATE DE SODIUM POUR PRÉPARATIONS INJECTABLESpoudre | — | SA |
| CEFTAZIDIME ANHYDREpoudre | 1 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.